Emergent BioSolutions Completes Acquisition of Sanofi’s Small-Pox Vaccine Business
By

By
Emergent BioSolutions, a specialty biopharmaceutical company and contract manufacturer, has completed its previously announced $117-million acquisition of Sanofi’s smallpox vaccine business, which includes ACAM2000 (a smallpox vaccine), two US manufacturing…

Sanofi, Regeneron Win Latest Patent-Infringement Battle with Amgen
By

By
Sanofi and Regeneron Pharmaceuticals, a Tarrytown, New York-based biopharmaceutical company, have scored a victory in ongoing patent litigation with Amgen over Sanofi’s/Regeneron’s Praulent (alirocumab) and Amgen’s Repatha (evolocumab), two new…

Amgen in Immuno-Oncology Pact Worth up to $1.4 Billion
By

By
Amgen and CytomX Therapeutics, a San Francisco, California-headquartered biopharmaceutical company, have formed a strategic collaboration, worth up to $1.4 billion, to co-develop bispecific antibody constructs for immuno-oncology. Amgen and CytomX…

Lonza Acquires US Clinical Biomfg Facility; On Track to Complete Cell Therapy Mfg Facility
By

By
In two separate developments, Lonza has agreed to acquire a clinical-stage mammalian manufacturing site in the US from Shire and is nearing completion of a cell and gene therapy manufacturing…

GE Healthcare Opens 3D-Printing Mfg Center for Pharma
By

By
GE Healthcare has opened its first 3D printing lab, called the Innovative Design and Advanced Manufacturing Technology Center for Europe, in Uppsala, Sweden. The center will use technologies, including 3D…

FDA Issues Draft Guidance for Generic-Drug Review Process
By

By
The US Food and Drug Administration (FDA) has issued two draft guidance documents for improving the generic drug review process when submitting abbreviated new drug applications (ANDAs). The first draft…

FDA Issues Draft Guidance for Complex Generic Drugs
By

By
In a move to facilitate the generic-drug review process and drug competition, the US Food and Drug Administration (FDA) has issued two draft guidance documents relating to the generic-drug review…

FDA OKs Mylan’s Generic of Teva’s Top-Selling MS Drug Copaxone
By

By
The US Food and Drug Administration (FDA) has approved two dosings of Mylan’s glatiramer acetate injection, a generic version of Teva Pharmaceutical Industries’ top-selling drug, Copaxone (glatiramer acetate), for treating…

Privacy Policy
By

By
Click here to read the full DCAT Terms of Use. Effective Date: January 20, 2020 Introduction The Drug, Chemical & Associated Technologies Association (“DCAT”) powers relationships and industry knowledge for…

CDMO/CMO Expansion in Parenteral Drug Development and Manufacturing
By

By
Contract development and manufacturing organizations (CDMOs) and contract manufacturing organizations (CMOs) have been expanding operations to support the development and manufacturing of parenteral drugs. So what are some key projects?…